Why file an Invokana Lawsuit?
In May of 2015, the FDA issued a warning that it had received multiple complaints concerning a number of SGLT2 inhibitor drugs causing ketoacidosis, which is a potentially fatal condition in which acid levels in the blood rise. This condition that is considered common among type 1 diabetes patients, but rare for those with type 2.
Some of the reasons people file lawsuits include:
- Financial hardship caused by emergency visits, ongoing care and lost wages
- Emotional distress from caring for loved ones suffering medical problems
- The burden of funeral expenses because an unexpected death
Invokana is a member of a newer class of diabetes drugs known as sodium-glucose co-transporter-2 (SGLT2) inhibitors that work by keeping blood sugar levels under control by helping the kidneys eliminate glucose from the bloodstream. Manufactured by drug pharmaceutical giant Johnson & Johnson and their Janssen Pharmaceuticals division, it was the first of the SGLT2 inhibitor group of medications to receive FDA approval.
Frequently Invokana is sold in a combination pill with metformin and doctors also recommend it be used in conjunction with a healthy diet and exercise to treat type 2 diabetes. Invokana should not considered safe for anyone with kidney disease or on dialysis, nor is it intended to be used in the treatment of type 1 diabetes. There are also concerns Invokana might not be appropriate for users with liver disease, low blood pressure, imbalanced electrolytes, high cholesterol, or for users who are pregnant or nursing.
Despite medical and FDA consensus that Invokana is safe, there have been numerous instances of users suffering serious side effects. Many of these issues could ultimately turn out to be a problem with most SGLT2 inhibitors.
Many in the medical community are concerned that diabetes medications are part of a cycle of problem drugs that begin when patients are prescribed medication that increase the risk of developing type 2 diabetes to treat a health issue. Many popular statin drugs – used to lower cholesterol – fall into this category. One study published in May 2013 found that statins increased a user’s risk for developing type 2 diabetes by 10 to 22%. To avoid this, patients are prescribed additional medications, such as Invokana, to control their blood sugar, putting them on a drug cocktail that could product dangerous consequences.
Diabetes drugs can be life-saving, but unfortunately, those benefits come at a steep risk. According to a report published by the CDC, diabetes drugs are part of a group of four medications that are responsible for two-thirds of all emergency room visits by adult Americans.
Risks Associated with Invokana
Invokana works by blocking reabsorption of glucose by the kidneys and increasing excretion of glucose in the urine. Recent studies have found the drug also causes an increase in the body’s production of glucose.
There is also evidence patients with a high risk of cardiovascular disease suffered major events, such as heart attacks and strokes, within the first 30 days of taking Invokana. The medication has also been shown to increase LDL cholesterol levels. Despite the risk of heart attack and stroke associated with the drug, the FDA has yet to require a warning label be placed on the product. As a matter of fact, Invokana did not even receive unanimous approval from the FDA panel that reviewed the medication. Five out of 15 of the members advised against approving it and expressed concern it could be extremely dangerous for people with kidney disease.
NY Times Drug Dangers BMJ Reuters Medscape FDA